AhR Modulating Agent for the Topical Therapy of Plaque Psoriasis
- PMID: 34879453
- DOI: 10.1056/NEJMe2116301
AhR Modulating Agent for the Topical Therapy of Plaque Psoriasis
Comment on
-
Phase 3 Trials of Tapinarof Cream for Plaque Psoriasis.N Engl J Med. 2021 Dec 9;385(24):2219-2229. doi: 10.1056/NEJMoa2103629. N Engl J Med. 2021. PMID: 34879448 Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical